Yeji

$PCRX

Pacira BioSciences, Inc.

Runway:cash-flow +
NasdaqMarket cap: —CIK 0001396814

Upcoming catalysts

0 surfaced

No catalysts surfaced for PCRX yet.

Drug pipeline

exparel
zilretta
Management of osteoarthritis (OA)-related knee pain

Recent catalysts

FDA approvalNov 9, 2023· 940d ago· success
$PCRXPacira BioSciences, Inc.
exparel
“openFDA SUPPL (EFFICACY) approval of EXPAREL — application NDA022496”
FDA approvalOct 6, 2017· 3165d ago
$PCRXPacira BioSciences, Inc.
zilretta · Management of osteoarthritis (OA)-related knee pain
“On October 6, 2017, ZILRETTA (triamcinolone acetonide extended-release injectable suspension) was approved by the U.S. Food and Drug Administration as the first and only extended-release intra-articular therapy for patients confronting osteoarthritis (OA)- related knee pain.”